An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol. Continue Reading
A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City’s African-American and Latino communities. Continue Reading
Emerging Healthcare Solutions, Inc. was pleased on learning the news that Intel, The Mayo Clinic and GE Healthcare have launched a new initiative to study the care and cost benefits of home-based telemedicine for elderly patients with chronic illnesses. Continue Reading
The role of the NHS in responding to violence against women and children is the subject of a new report by an independent taskforce of experts including Gene Feder, Professor of Primary Health Care at the University of Bristol. Continue Reading
Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers.br /br /He’d been diagnosed with age-related macular degeneration (AMD), but the disease had not caused significant vision loss. It wasn’t until he had trouble seeing while driving, watching television Continue Reading
Dainippon Sumitomo Pharma America, Inc., a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd., today announced that the U.S. Food and Drug Administration recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review. Continue Reading
Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae-rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels. Continue Reading
It’s a silent epidemic that affects millions of Americans. Chronic Kidney Disease (CKD) is a life-threatening illness that can often be treated successfully if found early, and can be detected at an early stage using simple, inexpensive blood and urine tests. As part of its 2010 World Kidney Day awareness program, the physicians of Dallas Nephrology Associates urge everyone to know and track their “kidney number.” Continue Reading
Ontario Nurses’ Association (ONA) President Linda Haslam-Stroud, RN says that any government changes to health-care or hospital funding must ensure quality patient care first. Continue Reading
Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™. Continue Reading
